Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AMG 397 |
Trade Name | |
Synonyms | AMG-397|AMG397|Murizatoclax |
Drug Descriptions |
AMG 397 is a small molecule inhibitor of MCL1 that selectively disrupts the interaction with members of the Bcl2 family, potentially resulting in increased cellular apoptosis, decreased cell viability, and reduced tumor growth (Cancer Res 2020;80(16 Suppl):Abstract nr 6218). |
DrugClasses | MCL1 Inhibitor 18 |
CAS Registry Number | 2245848-05-7 |
NCIT ID | C156740 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AMG 397 | AMG 397 | 0 | 1 |
AMG 397 + Azacitidine | AMG 397 Azacitidine | 0 | 1 |
AMG 397 + Dexamethasone | AMG 397 Dexamethasone | 0 | 1 |
AMG 397 + Venetoclax | AMG 397 Venetoclax | 0 | 0 |